Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Haemophilia A With Inhibitors”

32 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 32 results

Testing effectiveness (Phase 2)Study completedNCT05421429
What this trial is testing

KN057 Multiple Dose Study in Moderately Severe to Severe Hemophilia

Who this might be right for
Hemophilia
Suzhou Alphamab Co., Ltd. 24
Not applicableWithdrawnNCT01051544
What this trial is testing

Study of First TIME Immunotolerance Induction in Severe Hemophilia A Patients With Inhibitor at High Risk of Failure: Comparison With FVIII Concentrates With or Without Von Willebrand Factor - RES.I.S.T. Naive

Who this might be right for
Severe Hemophilia A
City of Hope Medical Center
Post-approval studies (Phase 4)Study completedNCT03093480
What this trial is testing

Evaluate Efficacy of rFVIIIFc for Immune Tolerance Induction (ITI) in Severe Hemophilia A Participants With Inhibitors Undergoing the First ITI Treatment (verITI-8 Study)

Who this might be right for
Hemophilia A With Inhibitors
Bioverativ, a Sanofi company 16
Not applicableUnknownNCT02018393
What this trial is testing

Case-control Pilot Study of the Immune Modulating Effect of FEIBA on Patients With Haemophilia A and Inhibitors

Who this might be right for
Severe Haemophilia A With Inhibitors
Hospital Universitario La Paz 20
Post-approval studies (Phase 4)Study completedNCT03103542
What this trial is testing

Study of rFVIIIFc for Immune Tolerance Induction (ITI) in Haemophilia A Patients With Inhibitors Who Have Failed Previous ITI Therapies

Who this might be right for
Hemophilia A
Swedish Orphan Biovitrum 16
Not applicableUnknownNCT02324517
What this trial is testing

Ex Vivo Laboratory Assays Application for Therapy Tailoring in Patients With Severe Bleeding Disorders

Who this might be right for
Severe Hemophilia
Sheba Medical Center 300
Post-approval studies (Phase 4)Active Not RecruitingNCT05181618
What this trial is testing

Evaluate Overall Health, Physical Activity, and Joint Outcomes in Participants With Severe or Moderate Hemophilia A Without Factor VIII Inhibitors on Emicizumab Prophylaxis

Who this might be right for
Severe Hemophilia AModerate Hemophilia A
Hoffmann-La Roche 136
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06747416
What this trial is testing

KN057 Multiple Dose Study in Patients with Hemophilia a or Hemophilia B with or Without Inhibitors

Who this might be right for
Hemophilia a and B
Suzhou Alphamab Co., Ltd. 24
Testing effectiveness (Phase 2)UnknownNCT04592692
What this trial is testing

A Pharmacokinetic and Clotting Activity Study of FVIII-PEGLip

Who this might be right for
Hemophilia A With Inhibitor
Ascension Healthcare Development Limited 20
Early research (Phase 1)Study completedNCT01921855
What this trial is testing

Study of FVIIa Variant BAY86-6150 (B0189) in Subjects With Moderate or Severe Hemophilia Types A or B With or Without Inhibitors

Who this might be right for
Hemophilia AHemophilia B
Bayer 16
Testing effectiveness (Phase 2)Study completedNCT03196297
What this trial is testing

A Trial Evaluating Efficacy and Safety of Prophylactic Administration of Concizumab in Patients With Severe Haemophilia A Without Inhibitors

Who this might be right for
HaemostasisHaemophilia A
Novo Nordisk A/S 36
Large-scale testing (Phase 3)Looking for participantsNCT05611801
What this trial is testing

A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B

Who this might be right for
Hemophilia AHemophilia B
Pfizer 100
Post-approval studies (Phase 4)UnknownNCT02479087
What this trial is testing

Safety/Efficacy Study to Assess Whether FVIII/VWF Concentrate Can Induce Immune Tolerance in Haemophilia A Patients

Who this might be right for
Hemophilia A
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 20
Post-approval studies (Phase 4)Looking for participantsNCT06145373
What this trial is testing

Test a Medicine (Fitusiran) for Preventing Bleeds in People With Severe Hemophilia Who Previously Received Preventive Treatment With Emicizumab

Who this might be right for
Hemophilia A
Sanofi 20
Post-approval studies (Phase 4)Study completedNCT01561391
What this trial is testing

Safety and Efficacy of Activated Recombinant Human Factor VII in Haemophilia Patients With Inhibitors During and After Major Surgery

Who this might be right for
Congenital Bleeding DisorderHaemophilia A With InhibitorsHaemophilia B With Inhibitors
Novo Nordisk A/S 36
Early research (Phase 1)Looking for participantsNCT06703606
What this trial is testing

Learn About How Changing Therapy From Emicizumab to Marstacimab Affects People With the Severe Hemophilia A.

Who this might be right for
Severe Hemophilia A
Pfizer 15
Testing effectiveness (Phase 2)Ended earlyNCT04541628
What this trial is testing

Safety & Efficacy of Encapsulated Allogeneic FVIII Cell Therapy in Haemophilia A

Who this might be right for
Hemophilia A
Eli Lilly and Company 3
Large-scale testing (Phase 3)Active Not RecruitingNCT04431726
What this trial is testing

Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Subcutaneous Emicizumab in Participants From Birth to 12 Months of Age With Hemophilia A Without Inhibitors

Who this might be right for
Severe Hemophilia A
Hoffmann-La Roche 55
Large-scale testing (Phase 3)WithdrawnNCT02196207
What this trial is testing

Hemophilia Inhibitor Clinical Trials (INHIBIT) Platform

Who this might be right for
Severe Hemophilia A
Margaret Ragni
Large-scale testing (Phase 3)Ended earlyNCT05695391
What this trial is testing

Safety and Efficacy of FVIIa to Prevent Excessive Bleeding in Hemophilia Patients With Inhibitors Undergoing Major Surgery

Who this might be right for
Hemophilia
Laboratoire français de Fractionnement et de Biotechnologies 2
Next Page